Health ❯ Chronic Diseases ❯ Type 2 Diabetes ❯ Treatment Options

Semaglutide

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

A fresh approval plus a $499 cash offer signals a bid to widen access, blunt copycats.

Ozempic May Lower Alzheimer's Risk in Type 2 Diabetics, Study Finds